AI Therapeutics is a San Diego-based biotech company that leverages artificial intelligence to accelerate drug discovery and development processes. The company operates in the intersection of biotechnology and machine learning, applying AI algorithms to identify novel therapeutic targets, optimize drug candidates, and streamline clinical development pathways.
With $48 million in total funding through Series A, AI Therapeutics represents the growing trend of AI-powered drug discovery companies seeking to reduce the traditional 10-15 year timeline and billion-dollar costs associated with bringing new medicines to market. The biotech sector has seen significant investor interest in AI-driven approaches, as these technologies promise to improve success rates in clinical trials and accelerate the path from laboratory to patient care.
| Date | Round | Amount | Lead Investor |
|---|---|---|---|
| Jan 2026 | Series A | $48M | Lux Capital |
A San Diego biotech company using AI to accelerate drug discovery and development processes.
AI Therapeutics has raised $48M in total funding, with their most recent round being a Series A. The company operates in the Biotech sector.
AI Therapeutics operates in the Biotech sector. A San Diego biotech company using AI to accelerate drug discovery and development processes.
